Amedisys (AMED) reported 591.19millioninrevenueforthequarterendedJune2024,representingayear−over−yearincreaseof6.91.32 for the same period compares to 1.37ayearago.ThereportedrevenuecomparestotheZacksConsensusEstimateof579.34 million, representing a surprise of +2.05%. The company delivered an EPS surprise of +8.20%, with the consensus EPS estimate being $1.22.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Stree ...